Impact of large scale, multicomponent intervention to reduce proton pump inhibitor overuse in integrated healthcare system: difference-in-difference study

Proton pump inhibitors (PPIs) are one of the most commonly prescribed classes of drugs, but an estimated 25-70% of PPI users may not have an appropriate indication, depending on the clinical setting. For such patients, PPIs cause unnecessary healthcare spending and pill burden.